Imricor Medical Systems, Inc. (ASX:IMR)

Imricor Medical Systems Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	435	367	96	55	144	284
Market Cap Growth	281.62%	281.62%	74.29%	-61.62%	-49.27%	155.25%
Enterprise Value	444	379	103	45	126	271
Last Close Price	1.61	1.36	0.55	0.35	0.97	2.19
PS Ratio	280.74	237.01	106.62	46.01	150.33	311.76
PB Ratio	-36.51	-30.82	-7.50	5.00	4.67	7.60
P/TBV Ratio	-	-	-	5.00	4.67	7.60
EV/Sales Ratio	286.48	244.66	114.13	37.28	131.63	298.01
Debt / Equity Ratio	-2.88	-2.88	-1.22	0.59	0.08	0.09
Asset Turnover	0.06	0.06	0.06	0.04	0.02	0.03
Inventory Turnover	1.18	1.18	0.88	0.96	0.92	0.51
Quick Ratio	6.81	6.81	0.27	2.80	6.81	11.03
Current Ratio	7.79	7.79	0.86	4.67	8.30	12.58
Return on Equity (ROE)	-	-	-	-116.05%	-77.05%	-69.44%
Return on Assets (ROA)	-68.06%	-68.06%	-95.73%	-53.19%	-41.90%	-33.90%
Return on Capital (ROIC)	-128.95%	-128.95%	-151.39%	-59.77%	-45.67%	-37.07%
Earnings Yield	-11.02%	-13.06%	-34.47%	-46.23%	-18.85%	-5.69%
FCF Yield	-5.81%	-6.88%	-19.90%	-44.61%	-17.31%	-5.93%
Buyback Yield / Dilution	-43.03%	-43.03%	-7.46%	-11.42%	-18.76%	-81.97%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.